HomeCASBF • OTCMKTS
add
Cansino Biologics Inc
Previous close
$3.51
Year range
$1.86 - $4.22
Market cap
10.33B HKD
Avg Volume
258.00
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
In the news
Financials
Income Statement
Revenue
Net income
(CNY) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 189.15M | 353.40% |
Operating expense | 206.84M | -38.50% |
Net income | -55.28M | 92.12% |
Net profit margin | -29.22 | -103.11% |
Earnings per share | — | — |
EBITDA | -33.45M | 95.26% |
Effective tax rate | -1.77% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.54B | -19.00% |
Total assets | 8.13B | -17.81% |
Total liabilities | 3.08B | -21.72% |
Total equity | 5.06B | — |
Shares outstanding | 248.81M | — |
Price to book | 0.17 | — |
Return on assets | -2.31% | — |
Return on capital | -2.61% | — |
Cash Flow
Net change in cash
(CNY) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -55.28M | 92.12% |
Cash from operations | -106.05M | 72.95% |
Cash from investing | -284.69M | -396.58% |
Cash from financing | -260.68M | -18.42% |
Net change in cash | -653.65M | -42.15% |
Free cash flow | -197.41M | -1,155.42% |
About
CanSino Biologics, often abbreviated as CanSinoBIO, is a Chinese vaccine company. Wikipedia
CEO
Founded
Jan 13, 2009
Website
Employees
1,149